Edgen Stock·Dec 20 2025, 05:01Back
BioMarin Stock Jumps 17% on $4.8B Amicus Therapeutics Buy
Edgen Stock·Dec 20 2025, 05:01
[1] BioMarin to buy Amicus Therapeutics for $4.8 billion in rare disease bet - Reuters (https://www.reuters.com/legal/transactional/b ...)[2] BioMarin to Acquire Amicus Therapeutics for $4.8 Billion in All‑Cash Deal, Expanding Rare Disease Drug Portfolio - ts2.tech (https://ts2.tech/en/biomarin-to-acquire-amicu ...)[3] BioMarin to acquire Amicus Therapeutics for $4.8 billion - CNBC (https://www.cnbc.com/2025/12/19/biomarin-to-a ...)
